Sigma Healthcare (SIG) Stock Price, News & Analysis

Company Overview

Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies primarily in Australia. The company operates various aligned pharmacies, including branded pharmacies under the Amcal, Discount Drug Stores, Guardian, and PharmaSave brands. It also provides retail support services to its branded network of pharmacy members; dose administration aid services; and third and fourth-party logistics services to pharmaceutical manufacturers and other supplier partners. The company was founded in 1912 and is headquartered in Clayton, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 1.96 million shs
• Average Volume: N/A
• Market Capitalization: A$4.57 billion
• P/E Ratio: N/A
• Dividend Yield: 0.34%
• Price Target: N/A
• Consensus Rating: N/A

SIG Stock Analysis - Frequently Asked Questions

How were Sigma Healthcare's earnings last quarter?

Sigma Healthcare Limited (ASX:SIG) announced its quarterly earnings data on Wednesday, September, 5th. The company reported $0.01 EPS for the quarter. Sigma Healthcare had a negative trailing twelve-month return on equity of 0.35% and a negative net margin of 0.09%.

What other stocks do shareholders of Sigma Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sigma Healthcare investors own include aTyr Pharma (LIFE), Star Bulk Carriers (SBLK), Apollo Global Management (APO), ArcBest (ARCB), Carrier Global (CARR), Customers Bancorp (CUBI) and DuPont de Nemours (DD).

Company Calendar

• Last Earnings: 9/05/2018
• Today: 8/13/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Distribution
• Sub-Industry: Retail
• Current Symbol: ASX:SIG
• Previous Symbol: ASX:SIP
• CIK: N/A
• Web: sigmahealthcare.com.au
• Phone: +61-3-92159215
• Fax: N/A
• Employees: 30,900
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: 6.91
• Net Income: -A$3 million
• Net Margins: -0.09%
• Pretax Margin: N/A
• Return on Equity: -0.35%
• Return on Assets: 0.71%

Debt

• Debt-to-Equity Ratio: 15.82
• Current Ratio: 1.74
• Quick Ratio: 0.83

Sales & Book Value

• Annual Sales: A$3.48 billion
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 5.57
• Book Value: A$0.47 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,570,000,000
• Free Float: N/A
• Market Cap: A$4.57 billion
• Optionable: Not Optionable
• Beta: 0.27